Literature DB >> 8890244

Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells.

M A Stein1, D A Mathers, H Yan, K G Baimbridge, B B Finlay.   

Abstract

It is presumed, but not proven, that enteropathogenic Escherichia coli (EPEC) causes secretory diarrhea by altering ion transport in enterocytes. In this study we used the whole-cell, current clamp variant of the patch clamp technique to demonstrate that EPEC infection of HeLa and Caco-2 human epithelial cells reduces cell resting membrane potential. The observed reduction of resting membrane potential in HeLa cells results from EPEC-mediated signal transduction to the host cell but is not dependent upon EPEC-mediated elevation of levels of intracellular free calcium. These findings indicate that EPEC can directly alter the relative distribution of ions across epithelial host cell membranes. This may be relevant to the etiology of diarrhea caused by EPEC infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890244      PMCID: PMC174450          DOI: 10.1128/iai.64.11.4820-4825.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Ca2+ and cell death.

Authors:  P Nicotera; S Orrenius
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

2.  An inducible bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; A S Ho; G K Schoolnik
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

3.  Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells.

Authors:  B B Finlay; I Rosenshine; M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Ultrastructural and biochemical changes in human jejunal mucosa associated with enteropathogenic Escherichia coli (0111) infection.

Authors:  C J Taylor; A Hart; R M Batt; C McDougall; L McLean
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986-01       Impact factor: 2.839

5.  Calcium-calmodulin dependence of actin accretion and lethality in cultured HEp-2 cells infected with enteropathogenic Escherichia coli.

Authors:  T J Baldwin; M B Lee-Delaunay; S Knutton; P H Williams
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

Review 6.  Exploitation of host signal transduction pathways and cytoskeletal functions by invasive bacteria.

Authors:  I Rosenshine; B B Finlay
Journal:  Bioessays       Date:  1993-01       Impact factor: 4.345

7.  Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers.

Authors:  C Canil; I Rosenshine; S Ruschkowski; M S Donnenberg; J B Kaper; B B Finlay
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

9.  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.

Authors:  M S Donnenberg; C O Tacket; S P James; G Losonsky; J P Nataro; S S Wasserman; J B Kaper; M M Levine
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC), triggers a flux of inositol phosphates in infected epithelial cells.

Authors:  V Foubister; I Rosenshine; B B Finlay
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  25 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.

Authors:  Michele Visentin; Ersin Selcuk Unal; Rongbao Zhao; I David Goldman
Journal:  Cancer Chemother Pharmacol       Date:  2013-07-24       Impact factor: 3.333

Review 4.  Interaction of enteropathogenic Escherichia coli with host epithelial cells.

Authors:  I Nisan; C Wolff; E Hanski; I Rosenshine
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

5.  The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells.

Authors:  K A Taylor; C B O'Connell; P W Luther; M S Donnenberg
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Enteropathogenic Escherichia coli virulence genes encoding secreted signalling proteins are essential for modulation of Caco-2 cell electrolyte transport.

Authors:  G K Collington; I W Booth; M S Donnenberg; J B Kaper; S Knutton
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Expression of the EspB protein of enteropathogenic Escherichia coli within HeLa cells affects stress fibers and cellular morphology.

Authors:  K A Taylor; P W Luther; M S Donnenberg
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.

Authors:  N Jourdan; M Maurice; D Delautier; A M Quero; A L Servin; G Trugnan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

9.  Transport and metabolism of some cationic ubiquinone antioxidants (MitoQn) in Caco-2 cell monolayers.

Authors:  Yan Li; J Paul Fawcett; Hu Zhang; Ian G Tucker
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

10.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.